The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 05, 2019
Filed:
Dec. 09, 2015
Applicant:
Immurx, Inc., Lebanon, NH (US);
Inventors:
Cory Ahonen, Enfield, NH (US);
Randolph Noelle, Plainfield, NH (US);
Assignee:
IMMURX, INC., Lebanon, NH (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/39 (2006.01); A61K 39/29 (2006.01); A61K 39/00 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); C07K 16/28 (2006.01); A61K 31/7032 (2006.01); C07K 16/46 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39 (2013.01); A61K 31/7032 (2013.01); A61K 39/29 (2013.01); A61K 39/3955 (2013.01); A61K 39/39541 (2013.01); A61K 45/06 (2013.01); C07K 16/2878 (2013.01); C07K 16/468 (2013.01); A61K 2039/505 (2013.01); A61K 2039/55511 (2013.01); A61K 2039/55516 (2013.01); A61K 2039/57 (2013.01); C07K 2317/21 (2013.01); C07K 2317/24 (2013.01); C07K 2317/31 (2013.01); C07K 2317/74 (2013.01); C07K 2317/75 (2013.01); C07K 2317/76 (2013.01);
Abstract
Adjuvant combinations comprising at least one NKT activator, such as alpha-galactosylceramide (α-Gal-Cer) or iGb3, a CD40 agonist and optionally an antigen are disclosed. The use of these immune adjuvants for treatment of various chronic diseases such as cancers is also provided.